VSV-IFNbetaTYRP1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VSV-IFNbetaTYRP1, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma [Phase 1]